Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder

BACKGROUND: To make well informed treatment decisions for their patients, clinicians need credible information about potential risk for substantial weight gain. We therefore conducted a post-hoc analysis of clinical trial data, examining early weight gain as a predictor of later substantial weight g...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipkovich, Ilya, Jacobson, Jennie G, Hardy, Thomas A, Hoffmann, Vicki Poole
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566555/
https://www.ncbi.nlm.nih.gov/pubmed/18793440
http://dx.doi.org/10.1186/1471-244X-8-78

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566555/
https://www.ncbi.nlm.nih.gov/pubmed/18793440
http://dx.doi.org/10.1186/1471-244X-8-78

Ejemplares similares